Pediatric Hypertension: Measure for Age and Context

Lecture collection · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Use the correct pediatric reference, confirm persistence, and let severity and organ effects determine the urgency of investigation and treatment.

Interpret BP within the child’s reference framework. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Interpret BP within the child’s reference framework. Correct cuff and technique — Repeat an elevated reading; Age / sex / height — Use the appropriate pediatric framework; Confirm the phenotype — ABPM when indicated; Investigate and follow — Secondary clues, organ effects and growth. Adult thresholds do not apply to every child; reference framework changes with age. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Age changes the definition

For children under 13, use age-, sex-, and height-based percentiles with the AAP table’s lower absolute cutoffs. From age 13, stage 1 is 130–139/80–89 and stage 2 is ≥140/90 mmHg. An adult cutoff alone can miss hypertension in a small child.

Confirm the reading

Use a cuff sized to the arm, supported positioning, quiet rest, and a validated device. Repeat an elevated automated value by auscultation. Persistent diagnosis usually requires auscultatory-confirmed elevation at separate visits; severe symptoms or extreme readings need immediate assessment rather than routine waiting.

Use ABPM to resolve the phenotype

Pediatric ABPM helps confirm persistent hypertension and distinguish white-coat or masked patterns, especially in CKD or high-risk children. Use pediatric standards and an adequate recording; adult wake/sleep cutoffs cannot simply replace the relevant age/height framework.

Look for secondary clues

Review kidney/urinary history, birth history, medicines/stimulants, sleep symptoms, family history, and growth. Examine pulses and upper/lower limb pressures when appropriate. Younger age, severe hypertension, abnormal urinalysis, or impaired function increases concern for a secondary renal or vascular cause.

Decide when lifestyle is insufficient

Symptoms, stage 2 disease without a readily modifiable factor, LV hypertrophy, CKD/diabetes, or persistent hypertension despite lifestyle measures support medication evaluation. Work with the family on food, activity, and sleep without stigma; treatment should not wait indefinitely for weight loss.

Track organs and function

Recheck BP, growth, adherence, adverse effects, and drug-specific kidney/electrolyte labs. AAP’s usual treatment goal is below the 90th percentile and below 130/80 in adolescents; CKD may require a more specific ambulatory target under pediatric nephrology care.

Supporting evidence

Continue learning